Medicare decision hands Eli Lilly a weight-loss drug win, TheStreet reports

Medicare has handed Eli Lilly a major win on weight-loss drugs, TheStreet reports, without detailing the decision. The development is favorable for the company's obesity franchise.

Detected & updated continuously · Source: Nebula

Story subjects

Eli LillyMedicare

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula